about
Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic valueTreatment of early gastric cancer in the Western World.Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma.Oligometastatic Disease in Upper Gastrointestinal Cancer - How to Proceed?Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma.Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival.Validation of 2-mm tissue microarray technology in gastric cancer. Agreement of 2-mm TMAs and full sections for Glut-1 and Hif-1 alpha.Impact of the Weekday of Surgery on Outcome in Gastric Cancer Patients who Underwent D2-Gastrectomy.Defining Benchmarks for Transthoracic Esophagectomy: A Multicenter Analysis of Total Minimally Invasive Esophagectomy in Low Risk Patients.[Quality of life and visceral surgery].Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy-A propensity score-matched comparison.Clinical outcomes of intraoperative manual dilatation of pylorus in pylorus-preserving gastrectomy: a retrospective analysis.Web-Based Immersive Patient Simulator as a Curricular Tool for Objective Structured Clinical Examination Preparation in Surgery: Development and EvaluationSerious Games in Surgical Medical Education: A Virtual Emergency Department as a Tool for Teaching Clinical Reasoning to Medical Students[New aspects of neoadjuvant therapy of malignant tumors of the upper gastrointestinal tract]Simultaneous laryngopharyngeal pH monitoring (Restech) and conventional esophageal pH monitoring-correlation using a large patient cohort of more than 100 patients with suspected gastroesophageal reflux diseaseGastric cancer treatment in the world: GermanyNeoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched studyPreoperative staging of nodal status in gastric cancerEstablishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research ToolThe economic burden of endoscopic treatment for anastomotic leaks following oncological Ivor Lewis esophagectomyHistory of Esophagogastric Junction Cancer Treatment and Current Surgical Management in Western CountriesMultimodal Treatment Strategies in Esophagogastric Junction Cancer: a Western Perspective
P50
Q26827351-7428E3E1-56C0-4C56-BFF6-545C6873292DQ33626791-7AF12223-D8EF-44C5-B99B-88DB1A35375DQ37012537-B19B47B0-8161-4DB6-8A77-3275A0586368Q38726779-CA3BE5C8-7C74-4D8B-9EFF-DE1594475983Q38983876-A1EEE591-2DFE-4BCE-A88D-142502DA17ECQ41068710-3633C59F-5176-48EC-9DE8-29F69C4DDC8AQ46219662-FE1CF201-D34B-4259-ACB4-B7DB28F8BA3BQ47559721-6ABA92C7-5DB8-4050-A71A-3F912015A04BQ49071820-F20E5DF0-2738-4830-B792-FB4A66A1EDC3Q50185212-740D53EA-CD69-45EF-AD73-5DC60D786F9AQ52656900-90A19570-6C2D-41B5-9B37-DA254D934E0CQ53079219-C77AF65A-7842-4B3A-BAFD-0F2CCD955AD8Q62634703-49DE657E-CAB7-4433-A248-3769BF9197AEQ64063823-2E00EA29-2DA5-4630-9485-4E89617102EAQ86713431-ABED3BED-64F1-43A2-BBFB-BBD84C650BA5Q88040899-12C66375-0EFA-4BE2-8042-EC23CE41E873Q88316204-AD910BCE-F8E6-465D-B4F4-3EEAE6A0803BQ88426986-EAAA517C-BD53-45A7-BDAB-77C03DFC4AC9Q89312977-A1AAEDEE-D767-459B-AD4C-360146DEAC58Q91743856-904272B8-F76D-4778-890F-38225426A657Q92956757-1EFF4AFD-7EA0-47D7-979F-471552180235Q93064534-95128204-922A-4126-9CF1-D15F84B60356Q93064544-8F2C8AF7-854F-46B3-824A-E1542AB024C2
P50
description
researcher ORCID ID = 0000-0002-3780-0728
@en
name
Felix Berlth
@ast
Felix Berlth
@en
Felix Berlth
@es
Felix Berlth
@nl
type
label
Felix Berlth
@ast
Felix Berlth
@en
Felix Berlth
@es
Felix Berlth
@nl
prefLabel
Felix Berlth
@ast
Felix Berlth
@en
Felix Berlth
@es
Felix Berlth
@nl
P1153
56099870500
P31
P496
0000-0002-3780-0728